In particular, Zhang et al. showed that in the HCT-116 cancer cell line, RHBDL4 knockdown led to decreased total β-catenin and decreased β-catenin phosphorylation at inhibitory positions serine 33, serine 37 and threonine 41. The gene discussed is RHBDD1; the disease is cancer.